130103-44-5Relevant articles and documents
HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS
-
Paragraph 000320, (2019/04/16)
Heterocyclic compounds of Formula (I), (II), and (III) are described herein along with their polymorphs, stereoisomers, prodrugs, solvates, co-crystals, intermediates, pharmaceutically acceptable salts, and metabolites thereof. The compounds described herein, their polymorphs, stereoisomers, prodrugs, solvates, co-crystals, intermediates, pharmaceutically acceptable salts, and metabolites thereof are PAD4 inhibitors and may be useful in the treatment of various disorders, for example rheumatoid arthritis, vasculitis, systemic lupus erythematosis, cutaneous lupus erythematosis, ulcerative colitis, cancer, cystic fibrosis, asthma, multiple sclerosis and psoriasis.
Diels-Alder reactions of 1,5-dihydropyrano[3,4-b]pyrrol-5(1H)-ones, pyrrole-2,3-quinodimethane analogues; a new synthesis of indoles
Mark Jackson,Moody, Christopher J.
, p. 7447 - 7466 (2007/10/02)
The pyrano[3,4-b]pyrrol-5-(1H)-ones 7 are stable cyclic analogues of pyrrole-2,3-quinodimethane, and undergo Diels-Alder reaction with a range of acetylenes (dimethyl acetylenedicarboxylate, ethyl propiolate, ethyl trimethylsilylpropynoate, benzyne and the acetylene equivalent, phenyl vinyl sulfoxide), to give, after loss of carbon dioxide, indoles. The Diels-Alder reaction can be extended to the intramolecular variant to give cycloalka-[e]- and [g]-indoles.
